David Arterburn, MD, MPH
@davearterburn
Internal medicine doc & researcher @KPWaResearch & @UWMedicine tweets on obesity, diabetes, bariatric surgery, shared decision making & related economics/policy
ID:3511081273
https://www.kpwashingtonresearch.org/our-research/our-scientists/arterburn-david-e/ 10-09-2015 03:10:14
2,5K Tweets
2,2K Followers
564 Following
This recent study by Kevin Hall is awesome.
It investigates the impact of different weight loss methods on the 'lipostat'-- the body fat regulatory system in the brain that opposes weight loss efforts.
My plain language summary.
doi.org/10.1002/oby.24…
A new paper from the Moving to Health study found that higher residential density was associated with lower increases in body mass index for children and adolescents. AJPM Focus bit.ly/3Um2OIR
Great talk at Obesity Medicine Association by David Arterburn, MD, MPH! What do we think is driving inpatient costs years after bariatric surgery? Is it reoperations, complications, something else? Identifying + reducing this is going to be critical for cost effectiveness
#obesitymedicine24 #OMA 24 #OMA
Grateful to JAMA Network
for publishing our cost-effectiveness analysis showing ESG provides greater #weightloss with cost savings compared to semaglutide for which the annual cost must be reduced 3-fold ($13,618 to $3591) to be cost-competitive. #GLP -1
jamanetwork.com/journals/jaman…
Worldwide bariatric procedures trends:
• Sleeve 58.2%
• RNY bypass 26.4%
• OAGB 7.6%
• Band 0.8
IFSO IFSO North America Chapter ASMBS Obesity Surgery Journal
doi.org/10.1007/s11695…
Results of our new trial to reduce sitting in older adults! We improved blood pressure. JAMA Network Open SBM Sedentary Behaviour Research Network
jamanetwork.com/journals/jaman…
Patients and physicians alike have forgotten that GLP-1 agonists such as Ozempic are just the latest medications for obesity, Daniel Engber writes. Older drugs are still available—and much easier to obtain. theatlantic.com/health/archive…